Suppr超能文献

僵人谱系障碍的实用治疗

Pragmatic Treatment of Stiff Person Spectrum Disorders.

作者信息

Balint Bettina, Meinck Hans-Michael

机构信息

Sobell Department of Motor Neuroscience and Movement Disorders UCL Institute of Neurology Queen Square, London UK.

Neuroimmunology Group, Nuffield Department of Clinical Neurosciences John Radcliffe Hospital Oxford UK.

出版信息

Mov Disord Clin Pract. 2018 Jul 19;5(4):394-401. doi: 10.1002/mdc3.12629. eCollection 2018 Jul-Aug.

Abstract

BACKGROUND

Stiff person spectrum disorders (SPSD) are a group of rare conditions clinically characterized by stiffness, spasms, and heightened stimulus sensitivity. They also share a spectrum of antibodies.

METHODS

We reviewed the literature and our own experience with the aim of providing a practical approach to the treatment of SPSD.

RESULTS

Because of the rarity of SPSD, there is little evidence to guide treatment decisions. The treatment of SPSD is based on the triad of symptomatic treatment, immunotherapy, and tumor treatment where appropriate. Moreover, the management involves continuous and appropriate monitoring of the symptoms of the disease, its autoimmune associations, and potential treatment side effects.

CONCLUSIONS

Here we delineated a pragmatic treatment approach to SPSD, based on our experience and existing literature. We also highlighted how our understanding of neuronal antibodies and their implications reflects on management considerations.

摘要

背景

僵人谱系障碍(SPSD)是一组罕见疾病,临床特征为僵硬、痉挛和刺激敏感性增强。它们还存在一系列抗体。

方法

我们回顾了文献及自身经验,旨在提供一种治疗SPSD的实用方法。

结果

由于SPSD罕见,几乎没有证据可指导治疗决策。SPSD的治疗基于对症治疗、免疫治疗及必要时的肿瘤治疗这三者。此外,管理还包括持续且适当地监测疾病症状、其自身免疫关联以及潜在的治疗副作用。

结论

在此,我们根据自身经验和现有文献,阐述了一种针对SPSD的实用治疗方法。我们还强调了我们对神经元抗体及其影响的理解如何反映在管理考量中。

相似文献

1
Pragmatic Treatment of Stiff Person Spectrum Disorders.僵人谱系障碍的实用治疗
Mov Disord Clin Pract. 2018 Jul 19;5(4):394-401. doi: 10.1002/mdc3.12629. eCollection 2018 Jul-Aug.
3
4
Stiff person syndrome spectrum disorders; more than meets the eye.僵人综合征谱障碍;比想象的更复杂。
J Neuroimmunol. 2022 Aug 15;369:577915. doi: 10.1016/j.jneuroim.2022.577915. Epub 2022 Jun 12.

引用本文的文献

5
Relevance of Antibody Testing in Movement Disorders.抗体检测在运动障碍中的相关性。
Mov Disord Clin Pract. 2023 Jun 12;10(Suppl 2):S32-S35. doi: 10.1002/mdc3.13772. eCollection 2023 Aug.
7
One in a Million: A Case Report of Stiff Person Syndrome.百万分之一:僵人综合征病例报告
Case Rep Rheumatol. 2022 Jan 13;2022:7741545. doi: 10.1155/2022/7741545. eCollection 2022.
8
Treatable Hyperkinetic Movement Disorders Not to Be Missed.不可漏诊的可治疗性运动亢进性疾病
Front Neurol. 2021 Dec 1;12:659805. doi: 10.3389/fneur.2021.659805. eCollection 2021.
9
From Collar to Coccyx: Truncal Movement Disorders: A Clinical Review.从颈部到尾骨:躯干运动障碍:临床综述
Mov Disord Clin Pract. 2021 Aug 26;8(7):1027-1033. doi: 10.1002/mdc3.13325. eCollection 2021 Oct.
10
Paraneoplastic neurological syndrome: an evolving story.副肿瘤性神经系统综合征:一个不断演变的故事。
Neurooncol Pract. 2021 Feb 24;8(4):362-374. doi: 10.1093/nop/npab002. eCollection 2021 Aug.

本文引用的文献

1
Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders.预测可治疗的僵人综合征谱系障碍的甘氨酸受体调节抗体。
Neurol Neuroimmunol Neuroinflamm. 2018 Jan 23;5(2):e438. doi: 10.1212/NXI.0000000000000438. eCollection 2018 Mar.
4
Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies.与抗ITPR1抗体相关的副肿瘤性小脑变性
Neurol Neuroimmunol Neuroinflamm. 2017 Feb 3;4(2):e326. doi: 10.1212/NXI.0000000000000326. eCollection 2017 Mar.
6
Serotonin-norepinephrine reuptake inhibitors may exacerbate stiff-person syndrome.血清素-去甲肾上腺素再摄取抑制剂可能会加重僵人综合征。
Neurol Neuroimmunol Neuroinflamm. 2016 Aug 29;3(5):e281. doi: 10.1212/NXI.0000000000000281. eCollection 2016 Oct.
9
Pediatric stiff-person syndrome with renal failure.小儿僵人综合征伴肾衰竭
J Neurosci Rural Pract. 2016 Jan-Mar;7(1):147-9. doi: 10.4103/0976-3147.165352.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验